19 Aug 2015 --- Tate & Lyle Ventures has announced a $2 million investment in Evolve BioSystems, Inc. a microbiome spin-out company from the University of California at Davis. Evolve is developing revolutionary science in the field of probiotics and prebiotics for new born infants during the crucial early months of development. The investment is part of a $9 million financing round led by Horizons Ventures and follows a seed investment by Tate & Lyle Ventures in August 2014.
